What does Otorino do?
OTORINO specializes in the development of innovative medical devices and solutions for ear, nose, and throat (ENT) conditions. The company focuses on enhancing patient care through advanced technology and research. Its products aim to improve diagnosis and treatment processes in the ENT field.
- Signals
-
ProfitableProfitable € 298K
The company reported a positive net result in the latest financial year.
Strong equityStrong equity € 1.65MStrong equity provides a buffer against setbacks.
Low riskLow risk 89.0%Good solvency (> 30%) points to long-term financial stability.
Good liquidityGood liquidity 10.01A healthy current ratio (≥ 1.5): enough current assets to cover short-term debt.
Positive cashflowPositive cashflow € 334KPositive operating cash flow in the latest financial year.
Positive EBITDAPositive EBITDA € 424KPositive EBITDA: operating activities are profitable.
Financial ratios
|
max) max = w;
}
}
const wClamped = Math.max(120, Math.min(800, max));
colWidths[''] = wClamped;
save && save();
})(event)">
|
2025
max) max = w;
}
}
const wClamped = Math.max(120, Math.min(800, max));
colWidths[''] = wClamped;
save && save();
})(event)">
|
2024
max) max = w;
}
}
const wClamped = Math.max(120, Math.min(800, max));
colWidths[''] = wClamped;
save && save();
})(event)">
|
2023
max) max = w;
}
}
const wClamped = Math.max(120, Math.min(800, max));
colWidths[''] = wClamped;
save && save();
})(event)">
|
2022
max) max = w;
}
}
const wClamped = Math.max(120, Math.min(800, max));
colWidths[''] = wClamped;
save && save();
})(event)">
|
|---|---|---|---|---|
|
€
428K
|
€
398K
|
€
265K
|
€
244K
|
|
|
€
424K
|
€
397K
|
€
265K
|
€
240K
|
|
|
€
298K
|
€
253K
|
€
168K
|
€
159K
|
|
|
€
1.65M
|
€
1.46M
|
€
1.25M
|
€
1.13M
|
|
|
89.03%
|
90.62%
|
85.05%
|
90.41%
|
|
|
€
203K
|
€
151K
|
€
220K
|
€
120K
|
|
|
€
1.76M
|
€
1.50M
|
€
1.32M
|
€
1.17M
|
Publications 29
All publications- Objet - Statuts (Traduction, Coordination, Autres Modifications, ) - Modification Forme Juridique 01/07/2021
- Me. - Comptes Annuels 31.12.2015, App 24.06.2016, Dpt 26.07.2016 16378-0052-010 04/08/2016
- Me. - Comptes Annuels 31.12.2014, App 26.06.2015, Dpt 16.07.2015 15307-0455-011 17/07/2015
- Me. - Comptes Annuels 31.12.2013, App 27.06.2014, Dpt 02.07.2014 14259-0490-011 07/07/2014
- Capital, Actions - Statuts (Traduction, Coordination, Autres Modifications, ) 15/01/2014
Frequently asked questions
Answers to the most common questions about Otorino, based on official government data and the filed annual accounts.
What is the VAT number of Otorino?
The VAT number of Otorino is BE0458.783.472.
When was Otorino established?
Otorino was founded in 12-09-1996.
What is the official address of Otorino?
The official address of Otorino is Rue Rombaut 80 Waterloo 1410.
What is the legal form of Otorino?
The juridical form of Otorino is Private limited company (BV/SRL).
What is the annual revenue of Otorino?
The 2025 accounts of Otorino do not report revenue. Smaller companies that file abbreviated accounts are not required to publish it.
What does Otorino do?
OTORINO specializes in the development of innovative medical devices and solutions for ear, nose, and throat (ENT) conditions. The company focuses on enhancing patient care through advanced technology and research. Its products aim to improve diagnosis and treatment processes in the ENT field.
Is Otorino a reliable company?
Otorino is a registered Rechtspersoon with company number 0458.783.472 and can be verified through the official CBE database.
What is the credit limit of Otorino?
The estimated credit limit of Otorino is €539,779.
Is Otorino still active?
Otorino currently has the status "Normal situation" and is active.